Randomized Phase III Study of Dexamethasone With or Without Genasense (Bcl-2 Antisense Oligonucleotide) in Patients With Relapsed or Refractory Multiple Myeloma.
Phase of Trial: Phase III
Latest Information Update: 10 Jan 2014
At a glance
- Drugs Oblimersen (Primary) ; Dexamethasone
- Indications Multiple myeloma
- Focus Registrational; Therapeutic Use
- Sponsors Genta
- 10 Jan 2014 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov
- 02 Jun 2009 Primary endpoint 'Time to disease progression' has not been met.
- 10 Sep 2005 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History